Are you living with overweight or obesity and do not have diabetes?
If so, you may be eligible to participate in a clinical research study evaluating an investigational GLP-1 medicine (LY900043) for weight management.
ABOUT THE STUDY
This is a Phase 2 study evaluatinghow LY900043 affects body weight.
WHO MAY QUALIFY?
You may be eligible to participate if you meet all the following:
Age 18 years or older
Body mass index (BMI) of 35 or higher (classified as obesity)
Do not have diabetes
Have never taken any glucose-lowering medications
Have not used any GLP-1-based medication — including pills or injections (such as Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound, Trulicity, or Foundayo) within the past 3 months
Have not used metformin within the past 3 months
Have never had surgery for treatment of obesity
INTERESTED IN LEARNING MORE?
Click below to complete a short questionnaire to see if you may be eligible.
Study Sponsor: Eli Lilly and Company